Younghee Choe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Younghee Choe has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Byung-Wook Kim
Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
6 shared publications - Joon Sung Kim
Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, Incheon, Korea
5 shared publications - Jae Myung Park
The Catholic University of Korea College of Medicine, Seoul, Korea (the Republic of)
3 shared publications - Yu Kyung Cho
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications - Gwang Ha Kim
Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea
2 shared publications - Hyung Jin Bae
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 10 June 2026
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 26 (2) , 255-256
Endoscopic Evaluation of a Gastric Mass Mimicking a Subepithelial Tumor
Endoscopic Evaluation of a Gastric Mass Mimicking a Subepithelial Tumor
- 10 June 2026
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 26 (2) , 255-256
Open AccessEndoscopic Evaluation of a Gastric Mass Mimicking a Subepithelial Tumor
Endoscopic Evaluation of a Gastric Mass Mimicking a Subepithelial Tumor
- Open Access
- 10 March 2026
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 26 (1) , 79-84
Natural History of Gastric Subepithelial Lesions Measuring 1 to 2 cm
Objectives: Management strategies for subepithelial lesions (SELs) measuring 1–2 cm remain undefined in most guidelines due to limited data. We aimed to establish a practical clinical approach by analyzing the long-term outcomes of SELs in this size range. Methods: We retrospectively reviewed cases of gastric SELs measuring 1–2 cm between 2011 and 2023. We reviewed esophagogastroduodenoscopy and endoscopic ultrasound images, alongside data from abdominal computed tomography, biopsy results, and long-term follow-up records. Results: Gastric SELs were initially identified in 648 patients. Of these, 88 patients (mean age, 57.1±10.6 years; 60% women) had lesions measuring 1–2 cm and underwent further evaluation or surveillance. The mean lesion size determined by endoscopy was 13.7±3.3 mm. Among the 52 patients with histological confirmation, 24 (46%) were diagnosed with gastrointestinal stromal tumors (GISTs), whereas the remainder had benign lesions. Most gastric SELs were located in the fundus and upper body. Pathological analysis indicated that the majority of GISTs were low-risk. Three GISTs were stratified as moderate-to-high risk; notably, one measured 0.9 cm upon pathological examination. The median surveillance period for the 28 patients without histological confirmation was 55 months (range, 43–115 months). Two of these patients underwent endoscopic or wedge resection due to tumor enlargement; both lesions were histologically confirmed as low-risk. Conclusions: Approximately half of the gastric SELs measuring 1–2 cm were GISTs, representing an intermediate- to high-risk tumors. Given that GISTs in the upper stomach were associated with elevated risk even when smaller than 2 cm, we recommend strict short-term surveillance for such lesions.
- 10 March 2026
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 26 (1) , 79-84
Open AccessNatural History of Gastric Subepithelial Lesions Measuring 1 to 2 cm
Objectives: Management strategies for subepithelial lesions (SELs) measuring 1–2 cm remain undefined in most guidelines due to limited data. We aimed to establish a practical clinical approach by analyzing the long-term outcomes of SELs in this size range. Methods: We retrospectively reviewed cases of gastric SELs measuring 1–2 cm between 2011 and 2023. We reviewed esophagogastroduodenoscopy and endoscopic ultrasound images, alongside data from abdominal computed tomography, biopsy results, and long-term follow-up records. Results: Gastric SELs were initially identified in 648 patients. Of these, 88 patients (mean age, 57.1±10.6 years; 60% women) had lesions measuring 1–2 cm and underwent further evaluation or surveillance. The mean lesion size determined by endoscopy was 13.7±3.3 mm. Among the 52 patients with histological confirmation, 24 (46%) were diagnosed with gastrointestinal stromal tumors (GISTs), whereas the remainder had benign lesions. Most gastric SELs were located in the fundus and upper body. Pathological analysis indicated that the majority of GISTs were low-risk. Three GISTs were stratified as moderate-to-high risk; notably, one measured 0.9 cm upon pathological examination. The median surveillance period for the 28 patients without histological confirmation was 55 months (range, 43–115 months). Two of these patients underwent endoscopic or wedge resection due to tumor enlargement; both lesions were histologically confirmed as low-risk. Conclusions: Approximately half of the gastric SELs measuring 1–2 cm were GISTs, representing an intermediate- to high-risk tumors. Given that GISTs in the upper stomach were associated with elevated risk even when smaller than 2 cm, we recommend strict short-term surveillance for such lesions.
- Open Access
- 10 December 2025
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 25 (4) , 389-393
Superficial Esophageal Cancer Completely Cured With Radiotherapy Alone: A Case Report
Surgery is the definitive treatment for superficial esophageal cancer. However, the risks and complications associated with surgery often lead to further complications. Endoscopic resection is an effective treatment option for superficial esophageal cancer. However, if the cancer invades more than three-quarters of the esophageal lumen, the risk of complications is high from both the procedure and potentially troublesome post-endoscopic esophageal stricture. To mitigate these issues, neoadjuvant radiotherapy or chemoradiotherapy may be administered before endoscopic resection to reduce the size of esophageal cancer. This report presents a case of complete remission of superficial esophagus cancer achieved with radiotherapy alone.
- 10 December 2025
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 25 (4) , 389-393
Open AccessSuperficial Esophageal Cancer Completely Cured With Radiotherapy Alone: A Case Report
Surgery is the definitive treatment for superficial esophageal cancer. However, the risks and complications associated with surgery often lead to further complications. Endoscopic resection is an effective treatment option for superficial esophageal cancer. However, if the cancer invades more than three-quarters of the esophageal lumen, the risk of complications is high from both the procedure and potentially troublesome post-endoscopic esophageal stricture. To mitigate these issues, neoadjuvant radiotherapy or chemoradiotherapy may be administered before endoscopic resection to reduce the size of esophageal cancer. This report presents a case of complete remission of superficial esophagus cancer achieved with radiotherapy alone.
- Open Access
- 10 June 2025
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 25 (2) , 126-133
Esophageal Mucosal Injuries From Drugs, Radiation, and Caustic Agents
Various factors can lead to esophageal mucosal injury. A thorough patient history is crucial to accurately diagnose esophageal injuries caused by drugs, radiation, and caustic agents. These conditions are often identifiable based on characteristic clinical features, concomitant diseases, and endoscopic findings and do not necessarily require histological confirmation through biopsies. Regardless of the underlying cause, avoiding or minimizing the offending agent is essential for preventing further mucosal damage. In cases where this is unavoidable, such as radiationinduced esophageal injuries, careful adjustment of the radiation dose, field, and frequency is necessary. Additionally, the use of mucosal protective agents and adherence to a soft diet can help regenerate the mucosal epithelium. Esophageal mucosal injuries can cause chronic complications, such as esophageal strictures; therefore, they require close monitoring. Notably, injuries induced by caustic agents carry an increased risk of progression to esophageal cancer, underscoring the importance of long-term surveillance.
- 10 June 2025
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 25 (2) , 126-133
Open AccessEsophageal Mucosal Injuries From Drugs, Radiation, and Caustic Agents
Various factors can lead to esophageal mucosal injury. A thorough patient history is crucial to accurately diagnose esophageal injuries caused by drugs, radiation, and caustic agents. These conditions are often identifiable based on characteristic clinical features, concomitant diseases, and endoscopic findings and do not necessarily require histological confirmation through biopsies. Regardless of the underlying cause, avoiding or minimizing the offending agent is essential for preventing further mucosal damage. In cases where this is unavoidable, such as radiationinduced esophageal injuries, careful adjustment of the radiation dose, field, and frequency is necessary. Additionally, the use of mucosal protective agents and adherence to a soft diet can help regenerate the mucosal epithelium. Esophageal mucosal injuries can cause chronic complications, such as esophageal strictures; therefore, they require close monitoring. Notably, injuries induced by caustic agents carry an increased risk of progression to esophageal cancer, underscoring the importance of long-term surveillance.
- Open Access
- 28 April 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 19 (3) , 364-375
Korean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line Treatment
Hyo-Joon Yang, Joon Sung Kim, Ji Yong Ahn, Ok-Jae Lee, Gwang Ha Kim, Chang Seok Bang, Moo In Park, Jae Yong Park, Sun Moon Kim, Su Jin Hong, Joon Hyun Cho ,Shin Hee Kim, Hyun Joo Song, Jin Woong Cho, Sam Ryong Jee, Hyun Lim, Yong Hwan Kwon, Ju Yup Lee, Seong Woo Jeon, Seon-Young Park, Younghee Choe, Moon Kyung Joo, Dae-Hyun Kim, Jae Myung Park, Beom Jin Kim, Jong Yeul Lee, Tae Hoon Oh, Jae Gyu Kim, and Korean College of Helicobacter and Upper Gastrointestinal Research. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240489
- 28 April 2025
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 19 (3) , 364-375
Open AccessKorean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line Treatment
Hyo-Joon Yang, Joon Sung Kim, Ji Yong Ahn, Ok-Jae Lee, Gwang Ha Kim, Chang Seok Bang, Moo In Park, Jae Yong Park, Sun Moon Kim, Su Jin Hong, Joon Hyun Cho ,Shin Hee Kim, Hyun Joo Song, Jin Woong Cho, Sam Ryong Jee, Hyun Lim, Yong Hwan Kwon, Ju Yup Lee, Seong Woo Jeon, Seon-Young Park, Younghee Choe, Moon Kyung Joo, Dae-Hyun Kim, Jae Myung Park, Beom Jin Kim, Jong Yeul Lee, Tae Hoon Oh, Jae Gyu Kim, and Korean College of Helicobacter and Upper Gastrointestinal Research. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240489
- Open Access
- 10 December 2024
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 24 (4) , 391-393
Efficacy of Vonoprazan-Tetracycline Dual Therapy in the Initial Treatment of Penicillin-Allergic Helicobacter pylori Infections
요 약 본 연구는 페니실린 알러지가 있는 환자의 헬리코박터 파일로리 감염에 대한 1차 치 료로서 보노프라잔-테트라사이클린 2제 요법의 효능과 안전성을 평가하는 것을 목표로 하는, 전향적 단일기관 개방형 비열등성 무작위대조군 연구(prospective, single center, open-label, non-inferiority, randomized controlled trial)이다. 1 300명을 대상으로 보 노프라잔-테트라사이클린 2제 요법(VT, vonoprazan 20 mg, 1일 2회+tetracycline 500 mg, 1일 3회)과 비스무스 4제 요법(BQT, lansoprazole 30 mg, 1일 2회+bismuth 150 mg, 1일 3회+metronidazole 400 mg, 1일 3회+tetracycline 500 mg, 1일 3회)으로 무작위로 배정하였다. VT 2제와 BQT의 제균율은 intention-to-treat (ITT) 분석에서 92% (95% 신뢰구간[confidence interval, CI], 86%-96%) vs. 89% (95% CI, 83%-94%; p=0.56), per-protocol (PP) 분석에서 95% (95% CI, 90%-98%) vs. 98% (95% CI, 93%-99%, p=0.25)로 유의한 차이가 없었고, 비열등성이 확인되었다(p-value for inferiority, p< 0.001 in ITT analysis and p=0.001 in PP analysis). 치료로 인한 부작용은 VT 2제에 서 유의하게 더 낮음을 보여주어, 헬리코박터 감염에 대한 1차 치료법으로서 BQT에 비 하여 효능과 안전성이 입증되어 페니실린 알러지 환자에서 좋은 대안이 될 수 있으며, 칼륨 경쟁적 위산분비 억제제(potassium-competitive acid blocker, PCAB) 기반 2제 요법을 더 확대할 수 있는 가능성을 보여주었다.
- 10 December 2024
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 24 (4) , 391-393
Open AccessEfficacy of Vonoprazan-Tetracycline Dual Therapy in the Initial Treatment of Penicillin-Allergic Helicobacter pylori Infections
요 약 본 연구는 페니실린 알러지가 있는 환자의 헬리코박터 파일로리 감염에 대한 1차 치 료로서 보노프라잔-테트라사이클린 2제 요법의 효능과 안전성을 평가하는 것을 목표로 하는, 전향적 단일기관 개방형 비열등성 무작위대조군 연구(prospective, single center, open-label, non-inferiority, randomized controlled trial)이다. 1 300명을 대상으로 보 노프라잔-테트라사이클린 2제 요법(VT, vonoprazan 20 mg, 1일 2회+tetracycline 500 mg, 1일 3회)과 비스무스 4제 요법(BQT, lansoprazole 30 mg, 1일 2회+bismuth 150 mg, 1일 3회+metronidazole 400 mg, 1일 3회+tetracycline 500 mg, 1일 3회)으로 무작위로 배정하였다. VT 2제와 BQT의 제균율은 intention-to-treat (ITT) 분석에서 92% (95% 신뢰구간[confidence interval, CI], 86%-96%) vs. 89% (95% CI, 83%-94%; p=0.56), per-protocol (PP) 분석에서 95% (95% CI, 90%-98%) vs. 98% (95% CI, 93%-99%, p=0.25)로 유의한 차이가 없었고, 비열등성이 확인되었다(p-value for inferiority, p< 0.001 in ITT analysis and p=0.001 in PP analysis). 치료로 인한 부작용은 VT 2제에 서 유의하게 더 낮음을 보여주어, 헬리코박터 감염에 대한 1차 치료법으로서 BQT에 비 하여 효능과 안전성이 입증되어 페니실린 알러지 환자에서 좋은 대안이 될 수 있으며, 칼륨 경쟁적 위산분비 억제제(potassium-competitive acid blocker, PCAB) 기반 2제 요법을 더 확대할 수 있는 가능성을 보여주었다.
- Open Access
- 10 December 2024
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 24 (4) , 346-352
Association Between Oral Health and Gastric Cancer in Korean Adults
Objectives: Poor oral hygiene is known to be associated with gastric cancer, but this remains controversial. In this study, we investigated the association between oral health and gastric cancer in Korean adults using data from the Korea National Health and Nutrition Examination Survey. Methods: We analyzed data of 79501 patients with gastric cancer and 41856805 individuals without gastric cancer (control group) using the 7th and 8th Korea National Health and Nutrition Examination Survey (2016–2019) records. Layer and colony variables and weights were used for the complex sample design. We performed logistic regression analysis of complex samples to analyze factors that affect gastric cancer development. Results: Patients with gastric cancer were older and had a higher prevalence of hypertension, hyperlipidemia, and diabetes and a higher rate of current smoking and alcohol consumption than individuals without gastric cancer (p<0.001). Regarding oral health-related factors, the prevalence of very uncomfortable chewing difficulty was significantly higher in patients with gastric cancer (14.4% vs. 3.6%, p<0.001). On multivariate analysis of factors associated with gastric cancer, chewing difficulty showed the highest odds ratio (5.351, 95% confidence interval 2.128–8.982). Patients with very uncomfortable chewing difficulty had high rates of previous dental nerve treatment, gum disease treatment, tooth extraction or intraoral surgery, and prosthetic repair (p<0.001). Conclusions: Oral health-related chewing difficulties were associated with gastric cancer, which may be attributable to poor oral hygiene and degradation of oral microbiota. Patients at risk of gastric cancer warrant timely medical interventions to address their oral health and chewing difficulties.
- 10 December 2024
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 24 (4) , 346-352
Open AccessAssociation Between Oral Health and Gastric Cancer in Korean Adults
Objectives: Poor oral hygiene is known to be associated with gastric cancer, but this remains controversial. In this study, we investigated the association between oral health and gastric cancer in Korean adults using data from the Korea National Health and Nutrition Examination Survey. Methods: We analyzed data of 79501 patients with gastric cancer and 41856805 individuals without gastric cancer (control group) using the 7th and 8th Korea National Health and Nutrition Examination Survey (2016–2019) records. Layer and colony variables and weights were used for the complex sample design. We performed logistic regression analysis of complex samples to analyze factors that affect gastric cancer development. Results: Patients with gastric cancer were older and had a higher prevalence of hypertension, hyperlipidemia, and diabetes and a higher rate of current smoking and alcohol consumption than individuals without gastric cancer (p<0.001). Regarding oral health-related factors, the prevalence of very uncomfortable chewing difficulty was significantly higher in patients with gastric cancer (14.4% vs. 3.6%, p<0.001). On multivariate analysis of factors associated with gastric cancer, chewing difficulty showed the highest odds ratio (5.351, 95% confidence interval 2.128–8.982). Patients with very uncomfortable chewing difficulty had high rates of previous dental nerve treatment, gum disease treatment, tooth extraction or intraoral surgery, and prosthetic repair (p<0.001). Conclusions: Oral health-related chewing difficulties were associated with gastric cancer, which may be attributable to poor oral hygiene and degradation of oral microbiota. Patients at risk of gastric cancer warrant timely medical interventions to address their oral health and chewing difficulties.
- Open Access
- 15 September 2024
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 24 (3) , 286-292
Endoscopic Treatment of Gastric Bezoars: A Report of Three Cases
Bezoars, including phytobezoars, trichobezoars, and pharmacobezoars, are accumulations of undigested substances in the gastrointestinal tract. We report three cases of gastric bezoars. Case 1: An 86-year-old woman presented with a one-month history of abdominal pain and vomiting. Esophagogastroduodenoscopy revealed gastric bezoars; consumption of 2 L of cola daily for 2 weeks resulted in complete disappearance of the bezoars. Case 2: An asymptomatic 63-year-old woman underwent esophagogastroduodenoscopy, which revealed a gastric bezoar. Cola spraying and endoscopic lithotomy were ineffective; therefore, the patient underwent laparoscopic removal of the bezoar for management of small bowel obstruction secondary to the bezoar fragments. Case 3: A 6-year-old girl with a history of pica underwent two laparoscopic surgeries 10 months apart for recurrent trichobezoars. We report our treatment approach in three patients who presented with gastric bezoars.
- 15 September 2024
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 24 (3) , 286-292
Open AccessEndoscopic Treatment of Gastric Bezoars: A Report of Three Cases
Bezoars, including phytobezoars, trichobezoars, and pharmacobezoars, are accumulations of undigested substances in the gastrointestinal tract. We report three cases of gastric bezoars. Case 1: An 86-year-old woman presented with a one-month history of abdominal pain and vomiting. Esophagogastroduodenoscopy revealed gastric bezoars; consumption of 2 L of cola daily for 2 weeks resulted in complete disappearance of the bezoars. Case 2: An asymptomatic 63-year-old woman underwent esophagogastroduodenoscopy, which revealed a gastric bezoar. Cola spraying and endoscopic lithotomy were ineffective; therefore, the patient underwent laparoscopic removal of the bezoar for management of small bowel obstruction secondary to the bezoar fragments. Case 3: A 6-year-old girl with a history of pica underwent two laparoscopic surgeries 10 months apart for recurrent trichobezoars. We report our treatment approach in three patients who presented with gastric bezoars.
- Open Access
- 25 March 2024
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 83 (3) , 81-86
Obesity and Upper Gastrointestinal Diseases
Younghee Choe. Korean J Gastroenterol 2024;83:81-6. https://doi.org/10.4166/kjg.2024.015
- 25 March 2024
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 83 (3) , 81-86
Open AccessObesity and Upper Gastrointestinal Diseases
Younghee Choe. Korean J Gastroenterol 2024;83:81-6. https://doi.org/10.4166/kjg.2024.015
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (6) , e66
Case 19: A 65-Year-Old Man With Melena and Hematochezia
Lee H, et al. J Korean Med Sci. 2024 Jan;39:e66. https://doi.org/10.3346/jkms.2024.39.e66
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (6) , e66
Open AccessCase 19: A 65-Year-Old Man With Melena and Hematochezia
Lee H, et al. J Korean Med Sci. 2024 Jan;39:e66. https://doi.org/10.3346/jkms.2024.39.e66